Form D · Pharmaceuticals
Acton Pharmaceuticals, Inc.
Marlborough, MA · CIK 0001478610
Offering snapshot reported May 20, 2013 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $295K Reported outside-investor minimum
- First sale
- May 13, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 20, 2013 | Initial | $7,000,005 | No comparison | 2 | SEC filing |
| Sep 30, 2010 | Initial | $14,199,512 | No comparison | 2 | SEC filing |
| Dec 15, 2009 | Initial | $500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-196737
Series A-2 Convertible Preferred Stock
Source: Form D, filed May 20, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Carter | Director |
| Daniel Kreisler | Director, Executive, Promoter |
| Thomas Phair | Executive |
| John Simon | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
225 Cedar Hill Street Suite 115
Marlborough, MA, 01752
Marlborough, MA, 01752